These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2475458)

  • 21. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J; de Torres Mateos JA
    Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.
    Curatolo C; Ludovico GM; Correale M; Pagliarulo A; Abbate I; Cirrillo Marucco E; Barletta A
    Eur Urol; 1992; 21 Suppl 1():105-7. PubMed ID: 1385127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult carcinoma of the prostate.
    El-Morsi AR
    J Egypt Med Assoc; 1974; 57(7-8):373-7. PubMed ID: 4452775
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
    Kuriyama M; Wang MC; Lee CL; Killian CS; Papsidero LD; Inaji H; Loor RM; Lin MF; Nishiura T; Slack NH; Murphy GP; Chu TM
    J Natl Cancer Inst; 1982 Jan; 68(1):99-105. PubMed ID: 6172628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).
    Roobol MJ; Kranse R; de Koning HJ; Schröder FH
    Urology; 2004 Feb; 63(2):309-13; discussion 313-5. PubMed ID: 14972478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen in adenocarcinoma of the prostate.
    N Engl J Med; 1988 Apr; 318(15):992-3. PubMed ID: 2451131
    [No Abstract]   [Full Text] [Related]  

  • 29. Benign positive margins after radical prostatectomy means a poor prognosis--pro.
    Djavan B; Milani S; Fong YK
    Urology; 2005 Feb; 65(2):218-20. PubMed ID: 15708025
    [No Abstract]   [Full Text] [Related]  

  • 30. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
    Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
    Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benign positive margins after radical prostatectomy means a poor prognosis--con.
    Rubin MA; Montie JE
    Urology; 2005 Feb; 65(2):221-3. PubMed ID: 15708026
    [No Abstract]   [Full Text] [Related]  

  • 33. [The value of prostate-specific antigen].
    Wirth M
    Urologe A; 1991 May; 30(3 Suppl):6. PubMed ID: 1720907
    [No Abstract]   [Full Text] [Related]  

  • 34. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
    Noguchi M; Noda S
    J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenocarcinoma of the prostate gland.
    Boxer RJ
    Urol Surv; 1977 Jun; 27(3):75-94. PubMed ID: 331648
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostatic intraepithelial neoplasia and prostate-specific antigen.
    Brawer MK
    Urology; 1989 Dec; 34(6 Suppl):62-5. PubMed ID: 2481364
    [No Abstract]   [Full Text] [Related]  

  • 37. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB].
    Morishita N; Minami Y; Ogawa S; Saito Y
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):404-13. PubMed ID: 6206268
    [No Abstract]   [Full Text] [Related]  

  • 38. The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
    Aleyassine H; MacIsaac SG
    Clin Biochem; 1980 Jun; 13(3):109-12. PubMed ID: 7418193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical markers in prostatic cancer.
    Schacht MJ; Garnett JE; Grayhack JT
    Urol Clin North Am; 1984 May; 11(2):253-67. PubMed ID: 6203205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical markers for prostatic carcinoma.
    Fair WR
    Prog Clin Biol Res; 1987; 239():659-80. PubMed ID: 2443916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.